Bellerophon Therapeutics has announced positive data from its Phase 3 clinical trial investigating INOpulse in patients with pulmonary…
Articles by Diogo Pinto
Aria CV, a company developing medical devices for pulmonary hypertension (PH), won the TCT 2018 Shark Tank Competition,…
United Therapeutics and MannKind established a worldwide exclusive licensing and agreement to develop and commercialize a dry powder…
Levosimendan, an investigational therapy for pulmonary hypertension associated with heart failure and preserved ejection fraction (PH-HFpEF), was found to…
Antidote Technologies, a digital health company, and phaware global association, an organization advocating for pulmonary hypertension (PH)…
A man with pulmonary hypertension, the first international patient to receive an advanced but totally artificial heart known as…
Women who have hypertension or preeclampsia, a more severe condition that leads to damage in the internal organs,…
A type of extracorporeal membrane oxygenation (ECMO), a life support technique used to oxygenate the blood, was seen to significantly…
Apelin, a peptide naturally produced in the body, reduces resistance in the pulmonary vascular system (blood vessels) and improves cardiac…
Intravenous infusions of treprostinil can improve disease severity in children with pulmonary hypertension (PH) associated with congenital…
Acceleron Pharma, a biopharmaceutical company focused on rare diseases, has announced the start of the PULSAR Phase 2 clinical…
Clinical features of sarcoidosis-associated pulmonary hypertension are similar across patients in the U.S., Europe and Middle East, but treatment is…